Pharma Research Toronto
Pharma Research Toronto (Pharma Research) is a division of Hoffmann-La Roche Limited that is engaged in discovering and developing antibody therapeutics to cure cancer and other diseases. It principally develops antibody therapeutics for the treatment of breast, prostate, ovarian, colorectal, pancreatic, lung cancers, leukemia, and melanoma diseases. Pharma Research identifies monoclonal antibodies targeting various cancer indications through its technology platform, FunctionFIRST. This technology generates and selects therapeutic antibodies based on their activity and before the antigen is known. The company has developed a broad range of functional antibodies which include a pipeline of more than 400 antibody drug products. Pharma Research is headquartered in Ontario, Canada.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

